AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34237025 — intervention group
Group type: COMPARATOR
Intervention: TV documentary (TVD) group (n = 34) watching a TV documentary
Number of subjects: 104
Study 34237025 — intervention group
Group type: COMPARATOR
Intervention: Typical school duties (TSD) group (n = 36) performing regular school duties
Number of subjects: 104
Study 32817068 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg every 2 weeks
Number of subjects: 542
Study 32817068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study 35333210 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicep curls (4 sets of 10RM)
Number of subjects: 28
Study 35333210 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg extensions (4 sets of 10RM)
Number of subjects: 28
Study 35333210 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery period (4, 24, or 48 hours)
Number of subjects: 28
Study 34585336 — intervention group
Group type: EXPERIMENTAL
Intervention: HRank helmet
Number of subjects: 116
Study 34585336 — intervention group
Group type: COMPARATOR
Intervention: LRank helmet
Number of subjects: 116
Study 34585336 — intervention group
Group type: COMPARATOR
Intervention: Comparison between HRank and LRank helmets
Number of subjects: 116
Study 34252289 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg dasiglucagon
Number of subjects: 112
Study 34252289 — intervention group
Group type: COMPARATOR
Intervention: 1.0 mg recombinant glucagon (GlucaGen®)
Number of subjects: 112
Study 32091401 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BVS)
Number of subjects: 113
Study 35955124 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based smoking prevention program (four classes on smoking and secondhand smoke prevention)
Number of subjects: 0
Study 35955124 — intervention group
Group type: COMPARATOR
Intervention: Scheduled school activities (control group)
Number of subjects: 0
Study 33523189 — intervention group
Group type: EXPERIMENTAL
Intervention: FCHV-delivered intervention (home visits 3 times a year for health promotion counseling and blood glucose monitoring)
Number of subjects: 244
Study 33523189 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 244
Study 33523189 — intervention group
Group type: EXPERIMENTAL
Intervention: FCHV-delivered intervention
Number of subjects: 244
Study 35556864 — intervention group
Group type: EXPERIMENTAL
Intervention: Competence‐based heterogeneous (CBH) student group formation and reciprocal peer teaching (RPT)
Number of subjects: 100
Study 33867169 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma simulations
Number of subjects: 49
Study 35413931 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with visual feedback on both force direction and magnitude
Number of subjects: 0
Study 35413931 — intervention group
Group type: COMPARATOR
Intervention: Training with visual feedback on force magnitude only (Control)
Number of subjects: 0
Study 32727732 — intervention group
Group type: EXPERIMENTAL
Intervention: Free glasses and a teacher incentive (tablet computer if ≥80% of children given glasses were wearing them on un‐announced examination)
Number of subjects: 728
Study 32727732 — intervention group
Group type: COMPARATOR
Intervention: Glasses prescription and letter to parents
Number of subjects: 728
Study 32213826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D
Number of subjects: 100
Study 32213826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33426938 — intervention group
Group type: EXPERIMENTAL
Intervention: Active fixation bipolar left ventricular lead
Number of subjects: 62
Study 33426938 — intervention group
Group type: COMPARATOR
Intervention: Quadripolar passive fixation LV lead
Number of subjects: 62
Study 33426938 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study 36367720 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended run-in varenicline treatment (4 weeks before quitting)
Number of subjects: 320
Study 36367720 — intervention group
Group type: COMPARATOR
Intervention: Standard run-in group (3 weeks of placebo followed by 1 week of varenicline)
Number of subjects: 320
Study 33587122 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 30522
Study 33587122 — intervention group
Group type: COMPARATOR
Intervention: Control (no vaccination in 2018)
Number of subjects: 30522
Study 32351612 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning applied on MORE homomorphic encrypted data
Number of subjects: 0
Study 32351612 — intervention group
Group type: EXPERIMENTAL
Intervention: Model trained on encrypted data for WBC hemodynamic model
Number of subjects: 0
Study 32351612 — intervention group
Group type: EXPERIMENTAL
Intervention: Privacy-preserving deep learning methods
Number of subjects: 0
Study 35331787 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent dietary role modeling of fruit intake at meals
Number of subjects: 114
Study 35331787 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent dietary role modeling of fruit as a snack
Number of subjects: 114
Study 35331787 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent fast food intake
Number of subjects: 114
Study 35331787 — intervention group
Group type: EXPERIMENTAL
Intervention: Child diet quality indicators (HEI-2015 total scores, FV intake, SSB intake)
Number of subjects: 114
Study 32472263 — intervention group
Group type: EXPERIMENTAL
Intervention: HydroSet bone substitute
Number of subjects: 0
Study 32472263 — intervention group
Group type: COMPARATOR
Intervention: No graft
Number of subjects: 0
Study 35026536 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating 4 Two trial
Number of subjects: 5
Study 34905884 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Assisted Surgery (CAS)
Number of subjects: 80
Study 34905884 — intervention group
Group type: COMPARATOR
Intervention: Personal Specific Instrumentation (PSI)
Number of subjects: 80
Study 36186646 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week therapeutic exercise program (7 × 60-min weekly sessions, supplemented by a home-based program 2-days/week)
Number of subjects: 21
Study 36186646 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 21
Study 36186646 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week therapeutic exercise program
Number of subjects: 21
Study 35800080 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance It
Number of subjects: 30
Study 35800080 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble Pop
Number of subjects: 30
Study 35800080 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoop'd
Number of subjects: 30
Study 32035749 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-target mean arterial pressure (MAP) of 40 to 50 mmHg
Number of subjects: 143
Study 32035749 — intervention group
Group type: COMPARATOR
Intervention: High-target mean arterial pressure (MAP) of 70 to 80 mmHg
Number of subjects: 143
Study 34342754 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered gut-directed hypnosis intervention (7 bi-weekly audio sessions over 3 months)
Number of subjects: 23
Study 34342754 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered gut-directed hypnosis intervention
Number of subjects: 23
Study 35672003 — intervention group
Group type: EXPERIMENTAL
Intervention: KARLOTTA app
Number of subjects: 30
Study 35672003 — intervention group
Group type: COMPARATOR
Intervention: Control group (no app)
Number of subjects: 30
Study 36410812 — intervention group
Group type: EXPERIMENTAL
Intervention: Encorafenib with cetuximab
Number of subjects: 0
Study 36410812 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab with FOLFIRI or irinotecan
Number of subjects: 0
Study 36410812 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0
Study 36410812 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab with FOLFIRI
Number of subjects: 0
Study 34521576 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led theory-based oral health intervention
Number of subjects: 1184
Study 34521576 — intervention group
Group type: COMPARATOR
Intervention: Control group (booklets for oral health promotion)
Number of subjects: 1184
Study 34338703 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-supplementation of Camelina sativa oil (CSO) and resistant dextrin
Number of subjects: 44
Study 33131932 — intervention group
Group type: COMPARATOR
Intervention: Post F-subunit vaccine
Number of subjects: 4
Study 33766681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8mg)
Number of subjects: 144
Study 33766681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 33007285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics (ceftazidime and tobramycin for 14 days combined with inhaled colistimethate sodium for 12 weeks)
Number of subjects: 286
Study 33007285 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics (ciprofloxacin for 12 weeks combined with inhaled colistimethate sodium for 12 weeks)
Number of subjects: 286
Study 33007285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics
Number of subjects: 286
Study 33007285 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 286
Study 35476700 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoantigen-based dendritic cell vaccination and neoantigen-activated T-cell therapy
Number of subjects: 10
Study 32696128 — intervention group
Group type: EXPERIMENTAL
Intervention: LI-ESWT (1 session/week for 4 weeks, 5000 shocks/session, 0.09 mJ/mm2 energy density)
Number of subjects: 76
Study 32696128 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 76
Study 32696128 — intervention group
Group type: EXPERIMENTAL
Intervention: LI-ESWT
Number of subjects: 76
Study 35945992 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-Free Anesthesia (OFA) with dexmedetomidine and lidocaine
Number of subjects: 75
Study 35945992 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil-based anesthesia (RA)
Number of subjects: 75
Study 35945992 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-Free Anesthesia (OFA)
Number of subjects: 75
Study 32497042 — intervention group
Group type: EXPERIMENTAL
Intervention: Hookworm infection
Number of subjects: 792
Study 32497042 — intervention group
Group type: EXPERIMENTAL
Intervention: Strongyloides stercoralis infection
Number of subjects: 792
Study 32497042 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infection with hookworm and S. stercoralis
Number of subjects: 792
Study 32497042 — intervention group
Group type: EXPERIMENTAL
Intervention: Age association with hookworm infection
Number of subjects: 792
Study 32497042 — intervention group
Group type: EXPERIMENTAL
Intervention: Age association with S. stercoralis infection
Number of subjects: 792
Study 35099230 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular Anxiety Skills Training (MAST-V); 6 sessions of 30 minutes each
Number of subjects: 6
Study 33530392 — intervention group
Group type: EXPERIMENTAL
Intervention: Projective Linear Reconstruction (PLR) algorithm
Number of subjects: 0
Study 35854636 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Leg Raising (PLR)
Number of subjects: 10
Study 35854636 — intervention group
Group type: COMPARATOR
Intervention: Head-Down Tilt (HDT)
Number of subjects: 10
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (1 g/kg BM)
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (1 g/kg BM)
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose and Fructose (0.5 g/kg BM)
Number of subjects: 15
Study 34836350 — intervention group
Group type: COMPARATOR
Intervention: Sucralose (0.2 g)
Number of subjects: 15
Study 34836350 — intervention group
Group type: COMPARATOR
Intervention: All conditions vs Sucralose
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose vs Fructose
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose vs Glucose and Fructose
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Glucose
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Fructose
Number of subjects: 15
Study 34836350 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lactate increase in Glucose and Fructose
Number of subjects: 15
Study 34836350 — intervention group
Group type: COMPARATOR
Intervention: Insulin levels in all conditions vs Sucralose
Number of subjects: 15
Study 33849715 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm cycling exercise plus traditional physiotherapy
Number of subjects: 30
Study 33849715 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy programme (control group)
Number of subjects: 30
Study 35109507 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-based cognitive intervention (Robot), 60-min session per day for 12 weeks.
Number of subjects: 37
Study 35109507 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (control), no cognitive intervention.
Number of subjects: 37
Study 32215888 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus of 200 μg 25OHD followed by daily infusion of 15 μg 25OHD for 10 days
Number of subjects: 24
Study 32215888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34857853 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen 4.4 mg/kg/day for 90 days
Number of subjects: 26
Study 34857853 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti-inflammatory medication)
Number of subjects: 26
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 30° without cushion support
Number of subjects: 23
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 45° without cushion support
Number of subjects: 23
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 60° without cushion support
Number of subjects: 23
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 30° with cushion support
Number of subjects: 23
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 45° with cushion support
Number of subjects: 23
Study 34889491 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm abduction at 60° with cushion support
Number of subjects: 23
Study 32325373 — intervention group
Group type: EXPERIMENTAL
Intervention: macimorelin 0.5 mg/kg
Number of subjects: 28
Study 32325373 — intervention group
Group type: EXPERIMENTAL
Intervention: macimorelin 1.0 mg/kg
Number of subjects: 28
Study 32325373 — intervention group
Group type: EXPERIMENTAL
Intervention: macimorelin 2.0 mg/kg
Number of subjects: 28
Study 32325373 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 2.5 mg/kg Q3W (Arm A)
Number of subjects: 200
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q3W (Arm B)
Number of subjects: 200
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 2.5 mg/kg Q6W (Arm C)
Number of subjects: 200
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q6W (Arm D)
Number of subjects: 200
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin 1.9 mg/kg Q6W (Arm E)
Number of subjects: 200
Study 36164180 — intervention group
Group type: EXPERIMENTAL
Intervention: All Arms (A-E)
Number of subjects: 200
Study 34098672 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 60
Study 34098672 — intervention group
Group type: COMPARATOR
Intervention: Placebo vitamin C 100 mg
Number of subjects: 60
Study 32057687 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance and music
Number of subjects: 93
Study 32057687 — intervention group
Group type: EXPERIMENTAL
Intervention: Music alone
Number of subjects: 93
Study 32057687 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 93
Study 35788767 — intervention group
Group type: EXPERIMENTAL
Intervention: PEITEM intervention (1-year, 6-component intervention via video teleconference)
Number of subjects: 1634
Study 35788767 — intervention group
Group type: EXPERIMENTAL
Intervention: PEITEM intervention
Number of subjects: 1634
Study 35788767 — intervention group
Group type: COMPARATOR
Intervention: Routine care plus stroke registry (control)
Number of subjects: 1634
Study 33452063 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-Assisted Language Intervention (TALI)
Number of subjects: 41
Study 33452063 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 41
Study 32798197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pestle needle therapy
Number of subjects: 154
Study 32798197 — intervention group
Group type: COMPARATOR
Intervention: Control (sham treatment with very light pressure)
Number of subjects: 154
Study 35644989 — intervention group
Group type: EXPERIMENTAL
Intervention: Single antipyretic use for relief of fever-related discomfort
Number of subjects: 602
Study 35644989 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyretics for febrile settled child with normal fluid intake
Number of subjects: 602
Study 35644989 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyretics for reduced fluid intake in febrile settled child
Number of subjects: 602
Study 35644989 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to give antipyretics to prevent febrile convulsions
Number of subjects: 602
Study 35644989 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT of antipyretics in febrile children <2 years of age
Number of subjects: 602
Study 32861819 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy boost (441 patients, 40.8%)
Number of subjects: 1082
Study 32861819 — intervention group
Group type: COMPARATOR
Intervention: No radiation therapy boost (641 patients, 59.2%)
Number of subjects: 1082
Study 36494054 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sarilumab (200 mg or 400 mg)
Number of subjects: 89
Study 36494054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 34579125 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily caloric restriction (DCR)
Number of subjects: 0
Study 34579125 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IMF)
Number of subjects: 0
Study 34579125 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32472958 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (16 mg intravenously at start of surgery)
Number of subjects: 51
Study 32472958 — intervention group
Group type: COMPARATOR
Intervention: Control (4 ml saline)
Number of subjects: 51
Study 616412020 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study 616412020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36124494 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (low dose 0.01 mg and high dose 0.1 mg)
Number of subjects: 4436
Study 36124494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4436
Study 36124494 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 4436
Study 33397376 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 154
Study 32270179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient 25(OH)D (≥32 ng/mL)
Number of subjects: 0
Study 32270179 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient 25(OH)D (<32 ng/mL)
Number of subjects: 0
Study 32270179 — intervention group
Group type: EXPERIMENTAL
Intervention: Offspring with asthma at age 3
Number of subjects: 0
Study 32270179 — intervention group
Group type: COMPARATOR
Intervention: Offspring without asthma at age 3
Number of subjects: 0
Study 35413905 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal normal saline instillation (INSI) of 15 mL/kg body weight
Number of subjects: 68
Study 35413905 — intervention group
Group type: COMPARATOR
Intervention: Conventional combination of open laparoscopic trocar valves with gentle abdominal pressure
Number of subjects: 68
Study 33539742 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard combined-modality treatment (2 + 2 regimen followed by 30 Gy involved-field radiotherapy)
Number of subjects: 1100
Study 33539742 — intervention group
Group type: COMPARATOR
Intervention: PET4-guided treatment (2 + 2 regimen followed by 30 Gy of involved-node radiotherapy only if PET positive)
Number of subjects: 1100
Study 33539742 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard combined-modality treatment
Number of subjects: 1100
Study 33539742 — intervention group
Group type: COMPARATOR
Intervention: PET4-guided treatment
Number of subjects: 1100
Study 34569991 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature extremes (minimum temperature <0 °C or maximum temperature >25 °C)
Number of subjects: 1598
Study 34569991 — intervention group
Group type: COMPARATOR
Intervention: Season (spring, summer, fall, winter)
Number of subjects: 1598
Study 34569991 — intervention group
Group type: COMPARATOR
Intervention: Temperature extremes and season
Number of subjects: 1598
Study 34185855 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodynamic nerve gliding (NDNG)
Number of subjects: 15
Study 34185855 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam rolling (FR)
Number of subjects: 15
Study 36267888 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-immersive virtual reality (VR) intervention
Number of subjects: 44
Study 36267888 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapies (CT)
Number of subjects: 44
Study 32866432 — intervention group
Group type: EXPERIMENTAL
Intervention: KRd regimen (36 mg/m2 of intravenous carfilzomib, 25 mg of oral lenalidomide, 40 mg of oral dexamethasone)
Number of subjects: 1087
Study 32866432 — intervention group
Group type: COMPARATOR
Intervention: VRd regimen (1.3 mg/m2 of bortezomib, 25 mg of oral lenalidomide, 20 mg of oral dexamethasone)
Number of subjects: 1087
Study 32866432 — intervention group
Group type: EXPERIMENTAL
Intervention: KRd regimen
Number of subjects: 1087
Study 32866432 — intervention group
Group type: COMPARATOR
Intervention: VRd regimen
Number of subjects: 1087